Heart Disease: Low-risk is not no-risk
Heart Disease: Low-risk is not no-risk
Most physicians recognize that cholesterol testing is a flawed tool for prediction of heart disease. To improve on the weaknesses of cholesterol testing, the Framingham risk score is often offered as a better risk-assessment tool, a prediction system based on the 60 years of observations coming from the residents of Framingham, Massachusetts. If we apply the Framingham risk scoring system to the U.S. population, several observations can…













